Matches in Nanopublications for { ?s ?p "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- NP271845.RAWk7g8ra7NNHD_PgWrDJFpmzoysjpp37OdvJfokdFC1I130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271845.RAWk7g8ra7NNHD_PgWrDJFpmzoysjpp37OdvJfokdFC1I130_provenance.
- NP332552.RAR_JjKuNti3-0zRQ96uucnxLXwLtltt9piq33mujufSQ130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332552.RAR_JjKuNti3-0zRQ96uucnxLXwLtltt9piq33mujufSQ130_provenance.
- NP210331.RA5sGF7gTqB56ju5wLyzrmMCaYZDXBMPH9EaLhVpheBOs130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210331.RA5sGF7gTqB56ju5wLyzrmMCaYZDXBMPH9EaLhVpheBOs130_provenance.
- NP362153.RAhxNsnvRtni1LQ0qsx6oDga2xQ2FiWcIYSg-7rj1xVTw130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362153.RAhxNsnvRtni1LQ0qsx6oDga2xQ2FiWcIYSg-7rj1xVTw130_provenance.
- NP451781.RAUIRiR9Ng5Uq1ZYbsBfPruUJs8iRHsoQFpgumP2qaZwY130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451781.RAUIRiR9Ng5Uq1ZYbsBfPruUJs8iRHsoQFpgumP2qaZwY130_provenance.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.
- NP94702.RAQyNQx-hwz96SAKrJgiGTPF7NzBLB_bkixoifIz9oRts130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94702.RAQyNQx-hwz96SAKrJgiGTPF7NzBLB_bkixoifIz9oRts130_provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP146709.RAXpp2O7z9HxUkt5jxoN7tCTgdjM1Zi_zM3jei2SLBXjk130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146709.RAXpp2O7z9HxUkt5jxoN7tCTgdjM1Zi_zM3jei2SLBXjk130_provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP146704.RACh3T6kBfPI6Qkwlu9qjd6pNIGOLJVeHMU6aXRwA69y8130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146704.RACh3T6kBfPI6Qkwlu9qjd6pNIGOLJVeHMU6aXRwA69y8130_provenance.
- NP670535.RALD48_WeS_jxkscvgSYxoU1onIQwZljFzhnXd7rriDOs130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670535.RALD48_WeS_jxkscvgSYxoU1onIQwZljFzhnXd7rriDOs130_provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP736991.RAZHKYPYOMMUUvsQ43kRjfopf6meJe7USk19vPOSLwAAU130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736991.RAZHKYPYOMMUUvsQ43kRjfopf6meJe7USk19vPOSLwAAU130_provenance.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.
- NP94454.RAGQ5X0YiQXXph8AyJG9udtf5-2yo72TKC94Wquc0Yggo130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94454.RAGQ5X0YiQXXph8AyJG9udtf5-2yo72TKC94Wquc0Yggo130_provenance.
- NP94703.RAFb2tQPK8_cJWtVfB9hBUDOCKfOo9PlUyPmINZCPK0o8130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94703.RAFb2tQPK8_cJWtVfB9hBUDOCKfOo9PlUyPmINZCPK0o8130_provenance.
- NP94455.RA34J7iqWD1SanDJxQFkI-h0RtgIFdtqvIX6Hug8uzoRg130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94455.RA34J7iqWD1SanDJxQFkI-h0RtgIFdtqvIX6Hug8uzoRg130_provenance.
- NP979256.RAlsj77ziU7mCb_U_x2cE07s6LL4Mg5CMk4EH7A7ZDYfo130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979256.RAlsj77ziU7mCb_U_x2cE07s6LL4Mg5CMk4EH7A7ZDYfo130_provenance.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.
- NP736992.RA7Lgl2GMc8y-sCIH83f07Y4YQ4MDvvVFgZmxphu03FUM130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736992.RA7Lgl2GMc8y-sCIH83f07Y4YQ4MDvvVFgZmxphu03FUM130_provenance.